426 - 450 of 6403 Results
Title
Year
-
OPENTitle: A Neurodegenerative Vascular Burden Index and the Impact on CognitionJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2014.00161Best OA location URL: https://pub.dzne.de/record/137515Citation Count: 15
-
OPENTitle: S-Nitrosylation of ApoE in Alzheimer’s DiseaseJournal Name: BiochemistryPublisher: American Chemical Society (ACS)Vol: 50Issue #: 17Start Page: 3405End Page: 3407Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/bi200266vBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3082618Citation Count: 39
-
OPENTitle: BACE1 Levels by APOE Genotype in Non-Demented and Alzheimer’s Post-Mortem BrainsJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 10Issue #: 3Start Page: 309End Page: 315Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1567205011310030010Best OA location URL: http://www.eurekaselect.com/article/50383Citation Count: 13
-
OPENTitle: Ephrin‐A5 regulates the formation of the ascending midbrain dopaminergic pathwaysJournal Name: Developmental NeurobiologyPublisher: WileyVol: 69Issue #: 1Start Page: 36End Page: 46Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/dneu.20685Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4026181Citation Count: 40
- Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse Model2013OPENTitle: Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse ModelJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 4Start Page: e61700End Page: e61700Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0061700Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0061700&type=printableCitation Count: 117
-
OPENTitle: Is PARKIN parkinsonism a cancer predisposition syndrome?Journal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 1Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000000031Best OA location URL: https://ng.neurology.org/content/nng/1/4/e31.full.pdfCitation Count: 4
-
OPENTitle: Hemispheric asymmetry of electroencephalography-based functional brain networksJournal Name: NeuroReportPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 25Issue #: 16Start Page: 1266End Page: 1271Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wnr.0000000000000256Citation Count: 10
-
OPENTitle: Relationship Between CSF Biomarkers of Alzheimer's Disease and Rates of Regional Cortical Thinning in ADNI DataJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 26Issue #: s3Start Page: 77End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-2011-0006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4587763Citation Count: 50
-
OPENTitle: Positive Florbetapir PET Amyloid Imaging in a Subject with Frequent Cortical Neuritic Plaques and Frontotemporal Lobar Degeneration with TDP43-Positive InclusionsJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 42Issue #: 3Start Page: 813End Page: 821Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-140162Best OA location URL: http://doi.org/10.3233/JAD-140162Citation Count: 23
-
OPENTitle: TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 126Issue #: 1Start Page: 51End Page: 57Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-013-1110-0Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3691299Citation Count: 90
-
OPENTitle: Alzheimer Research Forum Live Discussion: Mice on Trial? Issues in the Design of Drug StudiesJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 16Issue #: 1Start Page: 197End Page: 205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-2009-0961Best OA location URL: https://content.iospress.com:443/download/journal-of-alzheimers-disease/jad00961?id=journal-of-alzheimers-disease%2Fjad00961Citation Count: 1
-
OPENTitle: Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseJournal Name: Journal of Neuroscience ResearchPublisher: WileyVol: 91Issue #: 10Start Page: 1292End Page: 1302Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jnr.23253Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5800426Citation Count: 58
-
OPENTitle: Parkin mediates the degradation‐independent ubiquitination of Hsp70Journal Name: Journal of NeurochemistryPublisher: WileyVol: 105Issue #: 5Start Page: 1806End Page: 1819Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2008.05261.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4432938Citation Count: 99
-
OPENTitle: Toxic Oligomeric Alpha-Synuclein Variants Present in Human Parkinson’s Disease Brains Are Differentially Generated in Mammalian Cell ModelsJournal Name: BiomoleculesPublisher: MDPI AGVol: 5Issue #: 3Start Page: 1634End Page: 1651Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom5031634Best OA location URL: https://www.mdpi.com/2218-273X/5/3/1634/pdf?version=1437555461Citation Count: 37
-
OPENTitle: Impact of belief in neuroprotection on therapeutic intervention in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 8Start Page: 1082End Page: 1086Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22997Best OA location URL: https://europepmc.org/articles/pmc2891220?pdf=renderCitation Count: 1
-
OPENTitle: FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expressionJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 3Start Page: 455End Page: 459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22442Best OA location URL: http://doi.org/10.1002/mds.22442Citation Count: 44
-
OPENTitle: Par3 and aPKC regulate BACE1 endosome-to-TGN trafficking through PACS1Journal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 60Issue #:Start Page: 129End Page: 140Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.08.024Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5653456Citation Count: 24
-
OPENTitle: Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samplesJournal Name: Biotechnology ProgressPublisher: WileyVol: 29Issue #: 2Start Page: 463End Page: 471Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/btpr.1698Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3618510Citation Count: 24
-
OPENTitle: Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulatorsJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 25Issue #: 11Start Page: 2786End Page: 2799Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-018-0206-2Best OA location URL: https://www.nature.com/articles/s41380-018-0206-2.pdfCitation Count: 46
-
OPENTitle: Stress and the risk of multiple sclerosisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 22Start Page: 1866End Page: 1871Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31821d74c5Best OA location URL: https://n.neurology.org/content/neurology/76/22/1866.full.pdfCitation Count: 68
-
OPENTitle: Cognitive performance of GBA mutation carriers with early-onset PDJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 18Start Page: 1434End Page: 1440Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318253d54bBest OA location URL: https://n.neurology.org/content/neurology/78/18/1434.full.pdfCitation Count: 258
-
OPENTitle: Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding ActivitiesJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 412Issue #: 1Start Page: 94End Page: 110Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2011.07.033Citation Count: 123
-
OPENTitle: Calcium channel blocker use and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1818End Page: 1822Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23191Citation Count: 42
-
OPENTitle: Clinical expression of LRRK2 G2019S mutations in the elderlyJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2571End Page: 2576Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23330Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978804Citation Count: 23
- Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology2017OPENTitle: Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathologyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 7Start Page: 466End Page: 477Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.421Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.421Citation Count: 38